COVID-19 and Ehlers-Danlos Syndrome: The Dangers of the Spike Protein of SARS-CoV-2.

Fajloun, Ziad; Legros, Christian; Sabatier, Jean-Marc

Fajloun, Ziad; Legros, Christian; Sabatier, Jean-Marc.

Fajloun Z; Department of Biology, Faculty of Sciences 3, Lebanese University, Campus Michel Slayman Ras Maska, Tripoli 1352, Lebanon.
Legros C; Laboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and its Applications, EDST, Lebanese University, Tripoli 1300, Lebanon.
Sabatier JM; College of Life Sciences, University of Angers, INSERM, CNRS, MITOVASC, Team 2 CarMe, SFR ICAT, Angers 49000, France.

Infect Disord Drug Targets ; 23(3): e040123212375, 2023.

Article in English | MEDLINE | ID: covidwho-2197836

Subject(s)

COVID-19; Ehlers-Danlos Syndrome; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ehlers-Danlos Syndrome / COVID-19 Limits: Humans Language: English Journal: Infect Disord Drug Targets Journal subject: Communicable Diseases / Drug Therapy Year: 2023 Document Type: Article Affiliation country: 1871526523666230104145108

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google